PNOC ADVISORY COUNCIL
Jennifer Bartlett is the Director at Silicon Valley Bank (SVB). She was the first outside hire for the bank’s global loan syndications team, charged with creating and building SVB’s investment capabilities in middle market and corporate companies in the technology and life science sectors in the US, UK, EMEA, China, Hong Kong and Israel. In five years, Jennie led the growth of SVB’s total syndicated investments from $350.0 million to more than $6.0 billion. Prior to joining SVB, Jennie served in a variety of investment and operating capacities, many of which focused on the intersection of finance, policy and innovation. Most recently, she helped develop public-private underwriting partnerships and structure placements for $300.0 million in equity for the National Equity Fund (NEF), a leading syndicator of low income housing tax credits. Prior to NEF, Jennie served as a senior manager at Local Initiatives Support Corporation (LISC), the country’s largest community development finance institution. Jennie has a Bachelor of Arts in urban economics and neuroscience from Trinity College where she was a record-holding member of the varsity swimming team and a Masters in Business Administration from the Stephen M. Ross School of Business at the University of Michigan. Jennie lives in San Francisco and is an active member of the philanthropic community, having served on the board of Reading Partners and as a current mentor and member of the host committee for SHE-CAN.
Naoko Dalla Valle is the Founder and Proprietor of Dalla Valle Vineyards. Originally from Kobe, Japan, where her ancestors were Sake makers, Naoko and her husband Gustav shared a vision to produce world-renown Grand cru wines. Since Gustav’s death in 1995, Naoko has continued to realize that vision as sole proprietor of the couple’s Oakville estate, assisted by a formidable team of hand-picked experts. Under her inspired direction, Dalla Valle Vineyards maintains the strictest of standards and continues to scale the heights of quality. Naoko lost her 11-year-old nephew to Diffused Pontine Intrinsic Glioma (DIPG) a pediatric brain cancer. In 2014 she was the V Foundation Vintner Grant honoree, raising $350,000 to fight this form of cancer. The V Foundation made a grant in her name to PNOC’s Dr. Sabine Mueller, to help launch a DIPG clinical trial.
Chris Gallagher CEO and Co-founder, Vionic Group. Chris was born in Queensland, Australia and moved to Marin County in 2008, he has since relocated to Palm Beach Gardens, Florida. With over 30 years of experience in the footwear industry and a proven track record of building companies and brands that produce outstanding results. The Vionic brand is proof of that. With Chris’s vision and leadership, Vionic continues to create a thriving culture with a passionate leadership team who develops world class product and outstanding financial results. In 2017 and 2016 Chris was recognized by Footwear News as one of the top 100 most influential leaders in the global footwear industry. Chris is passionate about both the style and the biomechanics behind a great pair of shoes. He loves reading the life-changing reviews that consumers write about Vionic Shoes.
Tiffany Gomez, Senior Counsel and Director, Global Employment Law at Gap, Inc. Global in-house employment attorney providing advice on the domestic and international front. Her greatest strength is creating relationships and driving business results with practical advice across multiple jurisdictions while appropriately balancing risk.
Mike Jaszewski, Co-creator of Proton Man; Director, The Michael Jaszewski Studio. Mike has 20+ years of successful branding, designing, illustrating, and art directing for local and national companies. His satisfied clients range from start-ups to Fortune 500s. He co-created and illustrated the Proton Man comic with iconic comic book writer Steve Englehart best known for his work with Marvel Comics in the 70s and 80s. Proton Man was produced in partnership with Varian, written to give kids beginning Proton Therapy treatment (and their parents) an idea of what the treatment involved. The finished product is available to kids undergoing Varian's treatment, and anyone else who wants a copy. Mike is now working on the second installment.
Eric King is a seasoned fintech and software entrepreneur with over 20 years experience in building companies from start to successful exit. He was the Co-Founder & CEO of Sociogramics, a pioneering social/alternative data platform for underwriting and fraud management. Investors included Greylock, Trinity and QED. He was the first marketing executive and employee #7 at Clean Power Finance, the first solar financing platform to include SaaS-based account quoting tools for installers. The company has raised over $1B and is now known as Spruce Finance with funding from Kleiner Perkins and Google Ventures. Other milestones include being Co-Founder and President of FastFind, an online account acquisition service for mortgage and credit card lenders, Vice President of Corporate Development at Providian Financial. Function specific achievements include: Building FP&A teams from bottom-up at three startups, growing sales from $0 to $6mm in less than 12 months at FastFind, growing EBITDA from negative $500k to positive $1.5mm and sales by 50% in less than 12 months at ClickSafety and reducing shipping costs 40% and FTE 30% while increasing package throughput 40% at Elemental LED.
Jeff Kling has been Chief Creative Officer of Fallon Group, Inc. since August 2012. Mr. Kling served as Executive Creative Director, New York of Havas Worldwide, Inc. and worked at Wieden and Kennedy, in both Portland and Amsterdam, from 1996 to 2003. He was a Writer and Director of radio with Are These My Shoes Productions, where he produced award-winning work for BBDO's Pepsi and Visa accounts. He also worked with Chiat/Day on the NYNEX campaign and Ammirati & Puris on Burger King. He was responsible for noteworthy print for the Errol Morris film "Mr. Death," as well as print and promotional trailers for "Fight Club." Mr. Kling joined Euro RSCG New York as a Creative Director in 2003. He has overseen some of the agency's most fresh and compelling advertising and integrated communications for such clients as New Balance, Dos Equis, Volvo, The Partnership for a Drug-Free America and the AAAA's. Jeff was named "Copywriter of the Year" three times by the Association of Independent Commercial Producers (AICP). He created "The Most Interesting Man In The World," rubber-stamped Nike's "Write The Future" campaign and authored the Miller High Life manifesto. Other clients: Jaguar, Heineken, Coke, EA, Nokia, Volvo, Honda, The Eye Film Institute Netherlands, Miller Genuine Draft, ESPN, Clearasil, Gore-Tex, and more. He graduated magna cum laude from Duke University in 1989, with honors in English and German.
Shaughnessy Naughton, President, 314Action.org. Shaughnessy is an entrepreneur with a degree in chemistry and a passion for understanding the role of science in our everyday lives. With a background in research and drug discovery, Shaughnessy decided to get involved in politics because she is concerned about the future of science in the United States. In 2014, after running a business for over a decade, she stepped up to run for congress in Pennsylvania’s 8th District. With no prior political experience, she faced an uphill battle, to say the least. Ultimately, Shaughnessy was not successful, but she did receive a tremendous amount of support from the scientific community. Shaughnessy founded 314Action.org to encourage and unite the scientific community to do more than just advocate for science, and to get involved in the political process. Science is and always should be above politics. But too many politicians are taking on anti-science positions and we need to push back. The best way to do that is to ensure that like-minded, problem-solving engineers and scientists have a seat at the table. 314Action.org work’s to elect members of the STEM community and advance a pro-science agenda.
Heather Pilar Cunha Davis is an executive leader in oncology drug development. Heather’s expertise is in executive level project management leadership and operational experience with twenty-five years progressive experience in clinical trial project management focused on pivotal, early & late-phase oncology trials.
David Stoup, Chairman of Trilogy Spa Holdings has both founded and re-invented consumer product companies throughout his thirty plus years in the beauty business. Mr. Stoup’s prior experience includes his current position as Co-Chairman/CEO of Weil Lifestyle, LLC, as well as co-founding La Prairie, Inc., Phillip Kingsley Products, Inc., Colours & Scents and Perry Ellis Shoes, all of which were sold to strategic buyers. In 1992, Mr. Stoup secured the exclusive worldwide rights to operate the Red Door Spas under the Elizabeth Arden trade name from Unilever. As CEO, Mr. Stoup oversaw the growth of Elizabeth Arden Salon Holdings from two Red Door spas to 142 day spas in 26 markets throughout the United States and the United Kingdom, until its sale to a private equity group in May 2000. Mr. Stoup’s passion also extends to the non-profit world. He serves as a Member of the Board of Directors for the Amazon Conservation Team, Founder of YPO’s Global Youth Exchange and as a Board Member of St. Joseph’s Medical Center. He is also an active member of World Presidents Organization (WPO) and Chief Executives Organization (CEO).
Graham Weaver, Partner at Alpine Investors. Graham is the founder of Alpine Investors and spends nearly all his time helping develop the strategy, direction and priorities of the firm. Graham has been in private equity for over 20 years, starting Alpine in his dorm room at Stanford Business School. Graham holds an MBA from Stanford University and a Bachelors of Science in Engineering from Princeton University, where he graduated with highest honors and was captain of the national championship lightweight crew team.
Thomas Yang, Principal at Deloitte. Tom is a Principal (Partner) with over 15 years of experience in the life sciences industry. He serves as an adviser to Fortune 500 Companies on Growth Strategy with deep expertise in Healthcare and Life Sciences. He specializes in developing and implementing growth strategies across the product lifecyle, and is a leader of Monitor Deloitte's Product Launch practice. Tom has worked with clients to bridge the divide between Commercial and R&D to deliver growth through improved clinical development and commercialization. Specifically, these projects have focused on a range of topics such as: corporate strategy, business development, product development and commercialization strategy, market access, and building organizational capabilities. Tom received his Ph.D. in Cell and Molecular Biology from the University of Pennsylvania School of Medicine, where working with mouse models of breast cancer he characterized the role of a novel AMPK-family kinase in mammary tumorigenesis and metastasis. Tom graduated from Cornell University with a B.A. in Microbiology and Economics.